Description

**Basic purpose of the job:**

Manage the timely clinical development(CD) and Health Authority(HA) approval of NBI assets for target indications by providing appropriate and robust insights in [TA name] area, based on Japanese TA-specific and healthcare environment, in collaboration with Corporate&Japan (Early) Asset Team(s), (Early) Evidence Lead(s) and respective Evidence and Value Network

**Accountabilities:**

CD Strategy Planning:
- Evaluate and propose Japan (early)CD strategy to achieve asset Target Product Profile(TPP) and value proposition; Ensure CD strategy integrating Japan needs (including but not limited to local medical, competitive landscape and differentiation) in alignment with global asset strategy and agreed by Japan&Corp (early) Asset Team(s).
- Inform respective Evidence Network to highlight the local evidence gaps that are not addressed via Clinical Trials (CTs) for the relevant business function and their planning of Real World Evi...

Ready to Seal the Deal?

Submit your application today and take the next step in your career with Boehringer Ingelheim.

Apply for this Job